Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,002 other S bills in the 113th — cohort avg 39d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (9)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2014 · third_quarter · Taxation/Internal Revenue Code
S.336 / S.743 / H.R.684, Marketplace Fairness Act; H .R. 3086, Internet Tax Freedom Act; H.R. 4679 / S.2360, Stop Corporate Inversions Act of 2014; H.R.4457, America's Small Business Tax Relief Act of 2014; S. 2715, COMPETE Act of 2014; S. 193, Innovation Credit Act of 2013; Internet sales tax, sales tax on Internet access, research and development tax credit, inversions, section 179 and other extenders
Client expense: $190,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Institute of Standards & Technology (NIST), SENATE, Small Business Administration (SBA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2014 · third_quarter · Taxation/Internal Revenue Code
Corporate tax reform; all provisions of HR 4718 "To amend the Internal Revenue Code of 1986 to modify and make permanent bonus depreciation"; a strengthened and permanent U.S. R&D tax credit, including all such provisions in HR 4438 "American Research and Competitiveness Act of 2014", HR 3474 "Hire More Heroes Act of 2014", and HR4 "Jobs for America Act"; S2715 "Competitiveness and Opportunity by Modernizing and Permanently Extending the Tax Credit for Experimentation Act of 2014 or the COMPETE Act of 2014; tax policy issues related to corporate inversions including S2786 " Corporate Inverters Earnings Stripping Reform Act of 2014" and HR4679 & S2360 "Stop Corporate Inversions Act of 2014" and S2704 & HR5278 "No Federal Contracts for Corporate Deserters Act of 2014"; and all provisions of HR2835 and S 1647 "Restoring Access to Medication Act of 2013"
Client expense: $940,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Taxation/Internal Revenue Code
Renewable Chemicals/Bio-based Products S. 2260: EXPIRE Act of 2014Biofuels Accelerated Depreciation Extension Production Tax Credit Extension S. 2260: EXPIRE Act of 2014 Research & Development Tax Credit Reforms Extension Permanency H.R. 4438: American Research & Competitiveness Act of 2014 H.R.119: To amend the Internal Revenue Code to make permanent the credit for increasing research activities S. 2260: EXPIRE Act of 2014 S. 2715: The COMPETE Act S. 193: The Start-up Innovation Credit Act Capital Formation Investment Incentives Reform of Capital Gains Rules Reform of Net Operating Loss Rules Reform of Passive Loss Rules S. 2260: EXPIRE Act of 2014 H.R. 4855, the PARTNER Act S. 1658: The Start-up Jobs and Innovation Act HR 4855: To amend the Internal Revenue Code of 1986 to provide an exception from the passive loss rules for investments in high technology research small business pass-thru entities Tax Reform Orphan Drug Act Tax Credit Controlled Foreign Corporation Look-Through Rule Extension S. 2260: EXPIRE Act of 2014 Inversions H.R. 83: Consolidated and Further Continuing Appropriations Act for FY 2015
Client expense: $2,090,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Natl Security Council (NSC), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), U.S. Trade Representative (USTR), White House Office
2014 · fourth_quarter · Taxation/Internal Revenue Code
Implementation of P.L. 111-148, Patient Protection & Affordable Health Care Act Excise Tax for Drugs and Biologics Extension of R& D Tax Credit Orphan Drug Tax CreditImplementation of American Taxpayer Relief Act of 2012 Tax Reform H.R. 4438, American Research and Competitiveness Act of 2014 S. 2715, Competitiveness and Opportunity by Modernizing and Permanently Extending the Tax Credit for Experimentation Act of 2014 (COMPETE Act) Corporate Tax Inversions Issues S. 2786, Corporate Inverters Earnings Stripping Reform Act of 2014 S. 2704/H.R. 5278, No Federal Contracts for Corporate Deserters Act of 2014 H.R. 4679/S. 2360, Stop Corporate Inversions Act of 2014
Client expense: $370,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Taxation/Internal Revenue Code
Corporate tax reform; all provisions of HR 4718 "To amend the Internal Revenue Code of 1986 to modify and make permanent bonus depreciation," a strengthened and permanent U.S. R&D tax credit, including all such provisions in HR 4438 "American Research and Competitiveness Act of 2014," S 2715 "Competitiveness and Opportunity by Modernizing and Permanently Extending the Tax Credit for Experimentation Act of 2014 of the COMPETE Act of 2014," and in S 2260 "Expiring Provisions Improvement, Reform, and Efficiency Act of 2014 (or EXPIRE Act of 2014);" tax policy issues related to corporate inversions including S 2786 "Corporate Inverters Earning Stripping Reform Act of 2014" and HR 4679 & S 2360 "Stop Corporate Inversions Act of 2014" and S 2704 & HR 5278 "No Federal Contracts for Corporate Deserters Act of 2014;" and all provisions of HR 2835 and S 1647 "Restoring Access to Medication Act of 2013."
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Taxation/Internal Revenue Code
Corporate Tax Reform Amendments to S.2260 "Expire Act"; modifications to the R&D tax credit to allow contractors to be eligible to receive the credit. S.2715 "The Compete Act"
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Taxation/Internal Revenue Code
Corporate tax reform; all provisions of HR 4718 "To amend the Internal Revenue Code of 1986 to modify and make permanent bonus depreciation"; a strengthened and permanent U.S. R&D tax credit, including all such provisions in HR 4438 "American Research and Competitiveness Act of 2014", S2715 "Competitiveness and Opportunity by Modernizing and Permanently Extending the Tax Credit for Experimentation Act of 2014 or the COMPETE Act of 2014, and in S2260 "Expiring Provisions Improvement, Reform, andEfficiency Act of 2014 (or EXPIRE Act of 2014); tax policy issues related to corporate inversions including S2786 "Corporate Inverters Earnings Stripping Reform Act of 2014" and HR4679 & S2360 "Stop Corporate Inversions Act of 2014" and S2704 & HR5278 "No Federal Contracts for Corporate Deserters Act of 2014"; and all provisions of HR2835 and S 1647 "Restoring Access to Medication Act of 2013"
Client expense: $840,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Taxation/Internal Revenue Code
S.336 / S.743 / H.R.684, Marketplace Fairness Act; H .R. 3086, Internet Tax Freedom Act; H.R. 4679 / S.2360, Stop Corporate Inversions Act of 2014; H.R.4457, America's Small Business Tax Relief Act of 2014; S. 2715, COMPETE Act of 2014; S. 193, Innovation Credit Act of 2013; Internet sales tax, sales tax on Internet access, research and development tax credit, inversions, section 179 and other extenders
Client expense: $190,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Institute of Standards & Technology (NIST), SENATE, Small Business Administration (SBA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2014 · third_quarter · Taxation/Internal Revenue Code
Corporate tax reform International tax reform Research & Experimentation tax credit Renewable Energy tax credits Capital cost recovery Extension of expiring tax code provisions Expiring Provisions Improvement, Reform and Efficiency (EXPIRE) Act of 2014 (S.2260) Competitiveness and Opportunity by Modernizing and Permanently Extending the Tax Credit for Experimentation (COMPETE) Act, S. 2715
Client expense: $2,239,511 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Treasury, Dept of, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)
2014 · third_quarter · Taxation/Internal Revenue Code
Bonus Depreciation S. 2260: EXPIRE Act of 2014Tax Reform Orphan Drug Act Tax Credit Renewable Chemicals/Bio-based Products Bonus Depreciation for Renewable Chemical Facilities S. 2260: EXPIRE Act of 2014 Biofuels Accelerated Depreciation Extension Production Tax Credit Extension H.R. 3758: Second Generation Biofuel Extension Act of 2013 S. 2260: EXPIRE Act of 2014 Research & Development Tax Credit Reforms Extension Permanency H.R. 4438: American Research & Competitiveness Act of 2014 S. 2260: EXPIRE Act of 2014 S. 2715: The COMPETE Act S.193: The Start-up Innovation Credit Act Capital Formation Investment Incentives Reform of Capital Gains Rules Reform of Net Operating Loss Rules Reform of Passive Loss Rules H.R. 4855: The PARTNER Act S. 1658: The Start-up Jobs and Innovation Act S. 2715: The COMPETE Act Controlled Foreign Corporation Look-Through Rule Extension S. 2260: EXPIRE Act of 2014 Inversions H.R.4870: Department of Defense Appropriations Act for FY 2015 H.R.5016: Financial Services and General Government Appropriations Act for FY 2015
Client expense: $2,090,000 · Firm income: Not reported
2014 · third_quarter · Small Business
Sarbanes Oxley Section 404 (b) Mandatory Audit Firm Rotation H.R. 1564/S. 1526: The Audit Integrity and Job Protection ActCapital Formation Investment Incentives Reform of Capital Gains Rules Reform of Net Operating Loss Rules Reform of Passive Loss Rules S. 1658: The Start-up Jobs and Innovation Act H.R. 4855: The PARTNER Act S.2715: The COMPETE Act Expansion of Exemption under SEC Regulation A H.R. 4565: Startup Capital Modernization Act Proposed SEC Rule on Reg A+ Legislative Amendments to SEC Rule 12b-2 Filing Status Definitions H.R. 2629: The Fostering Innovation Act XBRL Exemption for Small Public Companies H.R. 4164: Small Company Disclosure Simplification Act H.R. 5405: The Promoting Job Creation and Reducing Small Business Burdens Act Stock Exchange Tick Size H.R. 3448: The Small Cap Liquidity Reform Act H.R. 1952: The Spread Pricing Liquidity Act Capital Market Enhancements H.R. 3623: Improving Access to Capital for Emerging Growth Companies Act H.R. 4568: Small Business Freedom to Grow Act H.R. 4569: Disclosure Modernization and Simplification Act H.R. 4571: To direct the SEC to revise its rules so as to increase the threshold amount for requiring issuers to provide certain disclosures relating to compensatory benefits plans H.R. 4697: To require the SEC to revise the definition of a WKSI to reduce the worldwide market value threshold under the definition
Client expense: $2,090,000 · Firm income: Not reported
2014 · third_quarter · Taxation/Internal Revenue Code
Implementation of P.L. 111-148, Patient Protection & Affordable Health Care Act Excise Tax for Drugs and Biologics Extension of R& D Tax Credit Orphan Drug Tax CreditImplementation of American Taxpayer Relief Act of 2012 Tax Reform H.R. 4438, American Research and Competitiveness Act of 2014 S. 2715, Competitiveness and Opportunity by Modernizing and Permanently Extending the Tax Credit for Experimentation Act of 2014 (COMPETE Act) Corporate Tax Inversions Issues S. 2786, Corporate Inverters Earnings Stripping Reform Act of 2014 S. 2704/H.R. 5278, No Federal Contracts for Corporate Deserters Act of 2014 H.R. 4679/S. 2360, Stop Corporate Inversions Act of 2014
Client expense: $330,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Taxation/Internal Revenue Code
Corporate tax reform; all provisions of H.R. 4718 "To amend the Internal Revenue Code of 1986 to modify and make permanent bonus depreciation"; a strengthened and permanent U.S. R&D tax credit, including all such provisions in H.R. 4438 "American Research and Competitiveness Act of 2014", H.R. 3474 "Hire More Heroes Act of 2014", and H.R. 4 "Jobs for America Act"; S. 2715 "Competitiveness and Opportunity by Modernizing and Permanently Extending the Tax Credit for Experimentation Act of 2014 or the COMPETE Act of 2014; tax policy issues related to corporate inversions including S.2786 "Corporate Inverters Earnings Stripping Reform Act of 2014" and H.R. 4679 & S. 2360 "Stop Corporate Inversions Act of 2014" and S. 2704 & H.R. 5278 "No Federal Contracts for Corporate Deserters Act of 2014"; and all provisions of H.R. 2835 and S. 1647 "Restoring Access to Medication Act of 2013"
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Science/Technology
Water research, technology and geoscienctists workforce issues, Frontiers in Innovation, Research, Science and Technology Act, H.R. 4186, H.R. 4159, H.R. 5189, S. 2715, S. 1971
Client expense: $60,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Bureau of Land Management (BLM), Energy, Dept of, Environmental Protection Agency (EPA), Federal Motor Carrier Safety Administration, HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE, U.S. Forest Service, U.S. Geological Survey (USGS)
2014 · third_quarter · Taxation/Internal Revenue Code
H.R. 3757 - Igniting American Research Act S. 2715 - The COMPETE Act
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Taxation/Internal Revenue Code
Corporate tax reform; all provisions of HR 4718 "To amend the Internal Revenue Code of 1986 to modify and make permanent bonus depreciation"; a strengthened and permanent U.S. R&D tax credit, including all such provisions in HR 4438 "American Research and Competitiveness Act of 2014", HR 3474 "Hire More Heroes Act of 2014", and HR4 "Jobs for America Act"; S2715 "Competitiveness and Opportunity by Modernizing and Permanently Extending the Tax Credit for Experimentation Act of 2014 orthe COMPETE Act of 2014; tax policy issues related to corporate inversions including S2786 " Corporate Inverters Earnings Stripping Reform Act of 2014" and HR4679 & S2360 "Stop Corporate Inversions Act of 2014" and S2704 & HR5278 "No Federal Contracts for Corporate Deserters Act of 2014"; and all provisions of HR2835 and S 1647 "Restoring Access to Medication Act of 2013"
Client expense: $940,000 · Firm income: Not reported
2014 · third_quarter · Taxation/Internal Revenue Code
Corporate Tax Reform Amendments to S.2260 "Expire Act"; modifications to the R&D tax credit to allow contractors to be eligible to receive the credit. S.2715 "The Compete Act"
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Security Council (NSC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), U.S. Trade Representative (USTR)
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Security Council (NSC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), U.S. Trade Representative (USTR)
Government targets: HOUSE OF REPRESENTATIVES, SENATE